ARWR (STOCKS)
Arrowhead Research Corporation
$77.150000
+2.630000 (+3.53%)
Prev close: $74.520000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Christopher Richard Anzalone
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,872.75M
- Employees
- 609
- P/E (TTM)
- -34.69
- P/B (TTM)
- 17.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
13
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q2)
|
$-0.93 | $-1.21 | +0.2810 | +23.20% |
|
Dec 2025 (Q1)
|
$0.22 | $0.26 | -0.0381 | -14.76% |
|
Sep 2025 (Q4)
|
$-0.18 | $-0.25 | +0.0656 | +26.71% |
|
Jun 2025 (Q3)
|
$-1.26 | $-1.05 | -0.2144 | -20.51% |
Financial Statements
| Revenues | $622.01M |
| Benefits Costs and Expenses | $874.27M |
| Costs And Expenses | $874.27M |
| Nonoperating Income/Loss | -$30.37M |
| Operating Expenses | $843.90M |
| Depreciation and Amortization | $25.37M |
| Research and Development | $687.51M |
| Operating Income/Loss | -$221.90M |
| Income/Loss From Continuing Operations After Tax | -$271.86M |
| Income/Loss From Continuing Operations Before Tax | -$252.26M |
| Income Tax Expense/Benefit | $19.60M |
| Net Income/Loss | -$271.86M |
| Net Income/Loss Attributable To Noncontrolling Interest | $29.05M |
| Net Income/Loss Attributable To Parent | -$300.91M |
| Net Income/Loss Available To Common Stockholders, Basic | -$300.91M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.17 |
| Diluted Earnings Per Share | -$2.17 |
| Basic Average Shares | 280,174,000 |
| Diluted Average Shares | 279,207,000 |
| Assets | $2.27B |
| Current Assets | $1.84B |
| Prepaid Expenses | $21.72M |
| Other Current Assets | $1.82B |
| Noncurrent Assets | $428.51M |
| Fixed Assets | $374.82M |
| Other Non-current Assets | $53.69M |
| Liabilities | $1.67B |
| Current Liabilities | $295.22M |
| Accounts Payable | $30.75M |
| Wages | $20.37M |
| Other Current Liabilities | $244.11M |
| Noncurrent Liabilities | $1.37B |
| Equity | $598.92M |
| Equity Attributable To Noncontrolling Interest | -$15.06M |
| Equity Attributable To Parent | $613.98M |
| Liabilities And Equity | $2.27B |
| Net Cash Flow From Operating Activities | -$36.31M |
| Net Cash Flow From Operating Activities, Continuing | -$36.31M |
| Net Cash Flow From Investing Activities | -$704.02M |
| Net Cash Flow From Investing Activities, Continuing | -$704.02M |
| Net Cash Flow From Financing Activities | $741.96M |
| Net Cash Flow From Financing Activities, Continuing | $741.96M |
| Net Cash Flow | $1.24M |
| Net Cash Flow, Continuing | $1.64M |
| Comprehensive Income/Loss | -$275.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $24.78M |
| Comprehensive Income/Loss Attributable To Parent | -$300.27M |
| Other Comprehensive Income/Loss | -$3.64M |